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Abstract
Background: Late-onset multiple acyl-CoA dehydrogenase deficiency (MADD) is an autosomal recessive inherited
disease of metabolic dysfunction clinically characterized by fluctuating proximal muscle weakness, excise
intolerance, and dramatic riboflavin responsiveness. Dropped head syndrome can occasionally be observed in
some severe patients with late-onset MADD; however, bent spine syndrome as an initial symptom had not been
reported in patients with late-onset MADD.
Case presentation: A 46-year-old man lost the ability to hold his trunk upright, and had difficulty in raising his
head, but he had no obvious symptoms of limb weakness. Meanwhile, he developed persistent numbness of limbs
and lips around. Myopathological features and combined elevation of multiple acylcarnitines indicated that the
axial myopathy might be caused by lipid storage myopathy. Cervical and lumbosacral MRI revealed a lot of
abnormal signals diffusing along paravertebral muscles, while the abnormal signals almost disappeared after
riboflavin treatment. Nerve conduction study indicated the patient suffering from predominantly sensory
neuropathy and mildly motor neuropathy. Muscle pathology also demonstrated no typical neurogenic change,
which was consistent with the electrophysiological findings. Causative mutations were found in the ETFDH gene.
Conclusion: We report the first case of late-onset MADD with sensory neuropathy initially manifesting as bent
spine syndrome and dropped head syndrome.
Keywords: Late-onset multiple acyl-CoA dehydrogenase deficiency, Bent spine syndrome, Dropped head syndrome,
Lipid storage myopathy, Peripheral neuropathy
Background
Bent spine syndrome (BSS) is defined as an unusual con-
dition characterized by progressive forward flexion of
the trunk [1, 2]. Selective involvement of paravertebral
muscles is the most common etiology of BBS, including
axial myopathy [3], motor neuron disease [4], myasthe-
nia gravis [5], and chronic inflammatory demyelinating
polyneuropathy [6].
Multiple acyl-CoA dehydrogenase deficiency (MADD)
is an autosomal recessive inherited disease of fatty acid
metabolism caused by deficiency of either electron trans-
fer flavoprotein (ETF) or ETF-ubiquinone oxidoreduc-
tase (ETF:QO) [7]. Most patients with late-onset MADD
can be dramatically resolved on treatment with ribo-
flavin, so this clinical phenotype is called as riboflavin
responsive MADD [8]. Besides the prominent muscular
symptoms of proximal limbs, extramuscular symptoms
of cardiac or gastrointestinal digestive system occasion-
ally can be observed in some patients with late-onset
MADD [9]. However, the involvement of peripheral
neuropathy is seldom described in patients with late-
onset MADD [10].
Some patients with late-onset MADD have weakness
of the neck extensor during the disease course, even
dropped head syndrome is observed in some severe
cases [11]. The coexisting of bent spine syndrome and
dropped head syndrome has been rarely reported in the
literature [12]. Late-onset MADD was not previously de-
scribed as a common cause of these two clinical features.
Herein, we presented the clinical and laboratory features
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of a 46-year-old man, who was diagnosed as late-onset
MADD with sensory neuropathy initially manifesting as
bent spine syndrome and dropped head syndrome.
Case presentation
A 46-year-old man was admitted to our clinical center
with symptoms of bent spine. He initially complained of
back and neck pain 3 months ago, and gradually had
trouble in standing upright 2 months ago, while the
symptoms would mildly alleviate when he had a rest. At
the same time, he felt numbness in limbs and around
lips. All of the symptoms gradually became more severe.
Two weeks ago, he completely lost the ability to hold his
trunk upright, and had difficulty in raising his head. The
patient had no obvious symptoms of limb weakness,
tremor, ataxia, and muscle cramp. He denied any family
history. Neurological examination revealed a posture of
bent spine and dropped head when standing up. Neck
extensor strength was 2/5 (MRCS, grades 0–5); Iliopsoas
muscle strength was 5-/5; proximal muscle strength of
lower limb was 5/5; and distal muscle strength was 5/5.
Deep tendon reflexes can not be elicited. Impairment of
light touch and pain sensation were found in hands, feet,
and lips around, while deep sensation was intact. Serum
creatine kinase (CK) was 568 IU/L (normal 25-175 IU/L).
Urinary organic acid analysis showed elevation of gluta-
rate, 2-hydroxyglutaric acid, 3-hydroxyglutaric acid, gly-
ceric acid, and 2-hydroxyadipic acid. Blood acylcarnitine
analysis revealed a combined elevation of short- (C6),
medium- (C8, C10), and long- (C14) chain acylcarnitines,
which was consistent with the metabolic disturbance of
MADD. Other routine blood tests were normal.
Electrophysiology showed that no sensory nerve action
potentials (SNAP) were elicited in any nerves except the
left ulnar nerve, which had decreased sensory conduc-
tion segmental velocities of 33 m/s across the left fore-
arm (normal >60 m/s), and a decreased amplitude of 2.8
millivolt (mV) in the left ulnar nerves (normal >7 mV).
In contrast, the results of motor nerve conduction stud-
ies were almost normal, except that compound muscle
action potential (CMAP) slightly decreased in some
nerves, as follows: 1.6 mV and 1.2 mV (normal >2.5 mV)
in bilateral peroneal motor nerves, respectively. The elec-
tromyogram parameters of proximal and distal limb mus-
cles were within normal limits.
Cervical magnetic resonance imaging (MRI) revealed a
few abnormal high signals infiltrating into cervical para-
vertebral mucles in T1 and T2 weighted images (Fig. 1a).
Fig. 1 Dynamic changes of muscular MRI. Cervical MRI revealed a few abnormal signals infiltrating into cervical paravertebral muscles in T2
weighted image (a, circle), while the abnormal signals almost disappeared after riboflavin treatment (b). Lumbosacral MRI showed a lot of
abnormal signals diffusing around musculi multifidus, musculi longissimus, and iliopsoas in T2 weighted images (c, ellipse), while the abnormal
signals almost disappeared after riboflavin treatment (d). Lower limb MRI showed normal pattern of musculi biceps femoris, musculi quadriceps
femoris (e), and gluteus maximus (f)
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Lumbosacral MRI showed a lot of high signals diffusing
around musculi multifidus, musculi longissimus, and
iliopsoas in T1 and T2 weighted images (Fig. 1c). Lower
limb MRI showed normal patterns of musculi biceps
femoris, musculi quadriceps femoris (Fig. 1e), and glu-
teus maximus (Fig. 1f ). After a written consent was
signed by patient in compliance with the bioethics laws
of China, open left quadriceps femoris and lumbar para-
vertebral muscle biopsies were performed. Hematoxylin
& eosin (HE) staining revealed a lot of small vacuoles in
paravertebral muscle fibers, but a few small vacuoles in
quadriceps femoris. The oil red O (ORO) staining
showed a significant increase of lipid droplets in paraver-
tebral muscle fibers (Fig. 2a), but a mild increase in
quadriceps femoris (Fig. 2b). No neurogenic features
were observed in acid and alkaline ATPases staining.
Genetic screening was performed in the alpha ETF
(ETFA), beta ETF (ETFB), and ETF dehydrogenase
(ETFDH) genes. A common mutation C.770A>G (p.T257C)
in Chinese population was identified in exon 7 of the
ETFDH gene (Fig. 3a). A novel mutation 920C>G
(p.S307C) was found in exon 8 of the ETFDH gene
(Fig. 3b). Substitution p.S307C is predicted to affect pro-
tein function with a score of 0.01 in Sorting Intolerant
From Tolerant (SIFT) software [13] and a score of 1.0 in
Polyphen2 software [14]. Blast software revealed that the
mutant residue had highly evolutional conservation [15].
The novel mutation was not found in 100 health Chinese.
After administration of riboflavin (60 mg/d, for 3 weeks),
the symptoms of bent spine and dropped head were com-
pletely resolved; the abnormal signals almost disappeared
in musculus semispinalis cervicis (Fig. 1b), transversospi-
nales and erector spinae (Fig. 1d); the muscle strength of
neck and limbs reached 5/5. The numbness in distal limbs
and around lips showed no any signs of improvement,
when the patient was interviewed after 3 weeks. However,
he reported a mild alleviation of numbness after persistent
administration of riboflavin (30 mg/d), CoQ10 (100 mg/d),
and Vitamin B12 (500 ug/d) for 6 months.
Discussion
In this report, we described a 46-year-old patient initially
presenting with bent spine syndrome and dropped head
syndrome. Acylcarnitine profile showed an elevation of
short-, medium- and long-chain acylcarnitines. Muscle
biopsy indicated lipid storage myopathy. Because of the
good response of muscle symptoms to riboflavin treat-
ment and genetic findings, the diagnosis of multiple acyl-
CoA dehydrogenase deficiency can be established [16].
Bent spine and dropped head syndromes are charac-
terized by an abnormal flexion of the trunk and neck
appearing in standing or walking position, both of which
can also be called as axial myopathy [17]. Axial myop-
athy is mainly caused by weakness of the paravertebral
muscles related to degradation of the muscular tissues,
independently of the increasing age [18]. Weakness of
the spinal extensor muscles can be secondary to various
diseases generating pathologic changes in the anti-
gravity muscles involved in trunk and neck extension.
Some patients with late-onset MADD had weakness of
neck extensor muscles, even presented as dropped head
syndrome in some severe cases [16]. However, the severe
weakness of paravertebral muscles had not been re-
ported in patients with late-onset MADD. Our patient
initially presented with bent spine syndrome, and then
gradually showed dropped head syndrome. However, the
patient had no obvious symptoms of limb weakness dur-
ing the disease course. To our knowledge, it is the first
case report of late-onset MADD presenting with bent
spine syndrome as the initial symptom.
Owing to the difficulty of obtaining biopsies from para-
vertebral muscles, muscular radiology is becoming a help-
ful diagnostic tool to various axial myopathies. Computed
tomography (CT) shows the commonest abnormality of
axial myopathy is significant low muscle density and fatty
infiltration that extends along the entire length of the
paravertebral muscles [19]. MRI features of axial myop-
athy also have similar muscular pattern with CT changes,
but the muscular MRI has a clearer contour profile than
Fig. 2 Muscular pathological features. ORO staining showed a significant increase of lipid droplets in myofibers of paravertebral muscles (a), but a
mild increase in myofibers of quadriceps femoris (b)
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muscular CT [20]. The limb muscle MRI doesn’t show
any obvious abnormalities in most patients with late-onset
MADD. Occasionally, some slightly high signals in T1 and
T2 weighted images were observed around musculi biceps
femoris in some severe patients [21]. There is no descrip-
tion about the MRI pattern of paravertebral muscles in
late-onset MADD. Our patient showed scattered fatty in-
filtration along the entire length of the paravertebral mus-
cles, while no significant fatty signals can be observed in
limb muscles. The phenomenon is consistent with the de-
gree of myofibers with lipid droplet deposition in our pa-
tient. After administration of riboflavin, the patient had
not only a complete recovery of axial muscle weakness,
but also an obvious recovery of the muscular pattern in
MRI. Dynamic changes of muscular MRI are a useful indi-
cator for the diagnosis of late-onset MADD.
Nerve conduction study indicated the patient suffering
from a predominantly sensory neuropathy and mildly
motor neuropathy. Muscle pathology of the patient dem-
onstrated no typical neurogenic change, which was con-
sistent with the electrophysiological findings including
prominent abnormalities of sensory nerves and slightly
axonal damage of motor nerves. It demonstrated that sen-
sory neuropathy can be one of the main manifestations in
this patient with late-onset MADD [10]. Recent studies
showed that zebrafish model of MADD displayed in-
creased neural cell proliferation, abnormal glial patterning,
reduced motor axon branching, as well as disorganized
sensory axonal tract with hypomyelination, and decreased
response to touch stimulation [22, 23]. Although the
neural phenotype in MADD zebrafish model is associated
with aberrant activation of the PPARG-ERK pathway and
mTORC1 signaling resulting from mitochondrial dysfunc-
tion and oxidative stress, the detailed pathomechanism
how mutant ETF-QO plays some roles in neurogenesis or
maintenance is still unclear [24]. Treatment with ribofla-
vin and coenzyme Q10 was quickly effective to resolve the
muscle weakness, as reported by others [25], but did not
resolve the sensory neuropathy in the same way. Accord-
ing to the fellow-up result, long-term administration of
riboflavin, coenzyme Q10 and vitamin B12 may be helpful
to reverse the damage of sensory nerves.
Defects of ETF:QO can cause dysfunction of the acyl-
CoA dehydrogenases, which leads to defects in electron
transfer generated by dehydrogenation reactions and
accumulation of multiple acyl-CoAs and metabolic sub-
strates in tissues [26]. The mutation p.257Tyr>Cys
locates in flavin adenine dinucleotide (FAD) domain,
and p.307Ser>Cys locates in ubiquinone (UQ) binding
region. The two mutations clustered in FAD/UQ binding
domain were similar to those in patients with classic
late-onset MADD, but the clinical phenotype of our
patient presented with great differences with classic late-
onset MADD. The mutations added two cysteine resi-
dues in the junctional region between FAD domain and
UQ binding domain [27]. The additional Cys residues
might crosslink with the inherent Cys residue at 248 and
266 positions, which can destroy the 3D structure of
ETF:QO. However, the muscular symptoms were effect-
ively responsive to riboflavin treatment, but the periph-
eral sensory neuropathy was difficult to be reversible,
which indicated the underlying pathogenic mechanisms
of neuropathy might be different from those of muscle
weakness. The genotype–phenotype correlation in this
patient is needed to elucidate further.
Conclusions
In summary, paravertebral muscles weakness can be pre-
dominant in some patients with late-onset MADD, even
can present with bent spine syndrome as the initial
symptom. Our case raises the awareness that bent spine
syndrome and dropped head syndrome as early symp-
toms is advised to consider the possibility of late-onset
MADD. Except for abnormalities of cardiac or gastro-
intestinal digestive systems, severe sensory neuropathy
can be one of the extramuscular manifestations in some
patients with late-onset MADD.
Patient consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the editor of this journal.
Fig. 3 Genetic chromatogram of the ETFDH gene. A mutation C.770A > G (p.257Tyr > Cys) in exon 7 of the ETFDH gene (a); another mutation
920C > G (p.307Ser > Cys) in exon 8 of the ETFDH gene (b)
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